Market Tracker

07/27 12:46pm ET

Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

4.18
BATS BZX Real-Time Price
As of 12:45pm ET
 -0.015 / -0.36%
Today’s Change
3.15
Today|||52-Week Range
9.49
+1.33%
Year-to-Date

Today’s Trading

Previous close4.20
Today’s open4.28
Day’s range4.18 - 4.28
Volume60,727
Average volume (3 months)1,485,163
Market cap$574.2M
Dividend yield--
Data as of 12:45pm ET, 07/27/2017

Growth & Valuation

Earnings growth (last year)-1,025.00%
Earnings growth (this year)-52.00%
Earnings growth (next 5 years)+5.23%
Revenue growth (last year)-77.31%
P/E ratioNM
Price/Sales37.63
Price/Book1.44

Competitors

 Today’s
change
Today’s
% change
DVAXDynavax Technologies...-1.15-11.06%
SCLNSciClone Pharmaceuti...-0.03-0.23%
PRTKParatek Pharmaceutic...-0.10-0.47%
OTICOtonomy Inc-0.10-0.51%
Data as of 12:46pm ET, 07/27/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$15.0M
Annual profit (last year)-$61.7M
Net profit margin-411.37%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Milind S. Deshpande
CFO, Principal Accounting Officer &
Executive VP
Mary Kay Fenton
Corporate headquarters
New Haven, Connecticut

Forecasts